Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical United States Compliance

FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Commissioner Hamburg asks for more power over non-traditional compounding to better regulate companies like the New England Compounding Center, but several House members say it looks like the agency already has the authority it needs.

You may also be interested in...



FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

FDA Drugs Field Staff May Be Based In Four Offices After Realignment

Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.

Table

View full table

Related Content

Pink Sheet HBW Insight Pink Sheet Pink Sheet Pink Sheet Pink Sheet Pink Sheet

Topics

Tags:
BioPharmaceutical United States Compliance
UsernamePublicRestriction

Register

PS073498

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By